Evidence map›Paper›PMID 35499983›Full record

ArticlePloS one2022

Dengue fever as a reemerging disease in upper Egypt: Diagnosis, vector surveillance and genetic diversity using RT-LAMP assay.

Mona Gaber, Alzahraa Abdelraouf Ahmad, Asmaa M El-Kady, Mohammed Tolba, Yutaka Suzuki, Shereen M Mohammed, Nahed Ahmed Elossily

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Investigating the Theoretical Possibility of Dengue Fever in Ancient Egypt.Journal of preventive medicine and hygiene · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mona GaberDepartment of Parasitology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Alzahraa Abdelraouf AhmadDepartment of Parasitology, Faculty of Medicine, Assiut University, Assiut, Egypt.ORCID 0000-0002-2947-3122
Asmaa M El-KadyDepartment of Parasitology, Faculty of Medicine, South Valley University, Qena, Egypt.
Mohammed TolbaDepartment of Parasitology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Yutaka SuzukiDepartment of Computational Biology and Medical Sciences, University of Tokyo, Kashiwanoha, Kashiwa, Chiba, Japan.
Shereen M MohammedDepartment of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Nahed Ahmed ElossilyDepartment of Parasitology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Assiut University · EGSouth Valley University · EGThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recent increase in dengue virus (DENV) outbreaks and the absence of an effective vaccine have highlighted the importance of developing rapid and effective diagnostic surveillance tests and mosquito-based screening programs. To establish effective control measures for preventing future DENV transmission, the present study was established to identify the main mosquito vector involved in the dengue fever (DF) outbreak in Upper Egypt in 2016 and detect the diversity of dengue virus serotypes circulating in both humans and vectors.

methodsWe investigated the prevalence of DENV infection and circulating serotypes in the sera of 51 humans clinically suspected of DF and 1800 field-collected Aedes aegypti adult female mosquitoes grouped into 36 pooled samples. Both DENV non-structural protein (NS1) immunochromatographic strip assay and loop-mediated isothermal amplification (LAMP) were used for screening.

resultsOverall, the rate of DENV infection in both human sera and pooled mosquito homogenate was 33.3%, as revealed by rapid dipstick immunochromatographic analysis. However, higher detection rates were observed with RT-LAMP assay of 60.8% and 44.4% for humans and vector mosquitoes, respectively. DENV-1 was the most prevalent serotype in both populations. A combination of two, three, or even four circulating serotypes was found in 87.5% of total positive pooled mosquito samples and 83.87% of DENV-positive human sera.

conclusionThe study reinforces the evidence of the reemergence of Aedes aegypti in Upper Egypt, inducing an outbreak of DENV. Mosquito-based surveillance of DENV infection is important to elucidate the viral activity rate and define serotype diversity to understand the virus dynamics in the reinfested area. Up to our knowledge, this is the first report of serotyping of DENV infection in an outbreak in Egypt using RT-LAMP assay.

Indexed as

AedesDengueDengue VirusAdultAnimalsEgyptFemaleGenetic VariationHumansMolecular Diagnostic TechniquesNucleic Acid Amplification Techniques

Identifiers

PMID35499983
PMCPMC9060354
OpenAlexW4225285717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.